Lv42
584 积分 2025-11-20 加入
Evaluation of ctDNA-based ESR1 testing in breast cancer: results from the first external quality assessment scheme in China
2个月前
已完结
Dalpiciclib or placebo plus fulvestrant in hormone receptor-positive and HER2-negative advanced breast cancer: a randomized, phase 3 trial
2个月前
已完结
Dalpiciclib plus letrozole or anastrozole versus placebo plus letrozole or anastrozole as first-line treatment in patients with hormone receptor-positive, HER2-negative advanced breast cancer (DAWNA-2): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
2个月前
已完结
Predictive ability of pancreatic cyst fluid biomarkers: A systematic review and meta-analysis
6个月前
已完结